Chronic inflammation is the “poor sister” of the big human di
Chronic inflammation is the “poor sister” of the big human diseases family. Infectious diseases, cancer, and many other diseases are managed under precision medicine protocols. On the contrary, chronic inflammation remains treated with immunosuppressive drugs mostly based on clinical guidelines, drug blood levels, and trial/error approaches.
Inflammatory diseases are clearly lacking a tool to determine the potency (efficacy) of immunosuppressive drugs over the immune cells of the patients, which are actually the target cells of the immunosuppressants/ immunomodulators.